Clinical study on estrogen supplementary treatment for urethra syndrome of menopausal women
- VernacularTitle:绝经后妇女尿道综合征雌激素补充治疗的临床研究
- Author:
Dianting ZHANG
;
Zhen LIU
- Publication Type:Journal Article
- Keywords:
Urethra syndrome;
Menopausal;
Estrogen supplementary treatment
- From:
Clinical Medicine of China
2001;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To improve the understanding,diagnosis and treatment for urethra syndrome of menopausal women.Methods 626 female patients with urethra syndrome took nilestriol of 2 mg/2 weeks orally after initating invalid antibiotic therapy.Then the therapeutic effects were observed and compared.Results 143 cases showed specially remarkable effect (2 weeks),426 cases presented remarkable effect (4 weeks),55 cases produced obvious effect (6 weeks) and 2 cases had common effect (8 weeks).The total effective rate was 100%.There was no complication.Conclusion Nilestriol supplementary treatment for urethra syndrome of menopausal women (1～2 mg/2 weeks) is safe and reliable with good effect.
